INTRODUCTION
Since its discovery in 1957 by Sutherland, cyclic adenosine 3',5'-monophosphate (cAMP) has been shown to play a major role as an intracellular second messenger in animal cells. Hormones, drugs, or toxins which alter intracellular cAMP levels in eucaryotic cells have pronounced effects on the metabolism and function of target cells. A number of bacterial toxins have been identified which elevate cAMP levels in mammalian cells, and it is likely that these toxins contribute to the pathogenicity of the bacteria that produce them. Furthermore, these toxins have been very useful tools in studying cAMP-regulated systems in both intact cells and broken cell preparations.
Several bacterial toxins have been shown to alter concentrations of intracellular cAMP in animal cells. Some of these toxins increase intracellular cAMP levels by catalyzing the transfer of an adenosine diphosphate-ribose moiety from nicotinamide adenine dinucleotide to guanine nucleotide regulatory proteins associated with mammalian adenylate cyclase (7, 31) . Cholera toxin, produced by Vibrio cholerae, and heat-labile enterotoxin, produced by Escherichia coli, catalyze the adenosine diphosphate-ribosylation of the (x subunit of Gs, the guanosine triphosphate-binding protein that couples stimulatory receptors to adenylate cyclase (2, 31, 32) . Islet-activating protein (IAP), also known as pertussis toxin, histamine-sensitizing factor, and lymphocytosispromoting factor, is produced by Bordetella pertussis and catalyzes the adenosine diphosphate-ribosylation of Gi, the guanosine triphosphate-binding protein that couples inhibitory receptors to adenylate cyclase (3, 21) . Recently, several acylpeptides isolated from the culture filtrates of Bacillus subtilis have been shown to increase cAMP in cultured mamnmalian cells by acting as potent inhibitors of mammalian cAMP phosphodiesterases (18) .
Two other unique toxins from B. pertussis and Bacillus anthracis possess intrinsic adenylate cyclase activity and are strongly stimulated by the eucaryotic regulatory protein calmodulin. Quite clearly, bacteria have been very versatile in devising mechanisms for elevating cAMP levels in animal cells. Presumably, there have been selective pressures for the evolution of these mechanisms. For example, high levels * Corresponding author.
of intracellular cAMP are toxic for many animal cells; an increase in intracellular cAMP can result in the breakdown and release of cellular energy stores. The toxins may also protect invasive bacteria from a host organism's phagocytic response. High levels of intracellular cAMP in polymorphonuclear neutrophils have been shown to inhibit several phagocyte-associated processes. This review is limited to the calmodulin-stimulated adenylate cyclases produced by B. pertussis and Bacillus anthracis.
ADENYLATE CYCLASE FROM B. PERTUSSIS B. pertussis is a small, gram-negative, noninvasive bacillus which is the etiologic agent of whooping cough. The disease is initiated by the invasion of the bacterium among the cilia of the respiratory epithelium. The bacterium produces a number of factors which are thought to play a role in pathogenesis (28, 30, 34, 46) . One of these factors is a calmodulin-sensitive adenylate cyclase which was first detected in crude vaccine preparations obtained from B. pertussis (52) . In addition, adenylate cyclase activity has been detected in several related bacterial strains, Bordetella parapertussis and Bordetella bronchiseptica (6) . A recent study has characterized calmodulin-sensitive adenylate cyclase activity associated with a 68,000-molecular-weight protein purified from the outer membrane of B. bronchiseptica (33) .
These calmodulin-sensitive bacterial adenylate cyclases are the only adenylate cyclases released extracellularly. Other bacterial adenylate cyclases are primarily membrane associated, like the E. coli adenylate cyclase, or cytoplasmic, as are the enzymes from Brevibacterium liquefaciens or Staphylococcus salvarius (20) . The B. pertussis enzyme is soluble. It is released into the culture media of bacteria, and it reaches peak activity during the exponential growth phase (6, 13, 16, 28) . Release of adenylate cyclase into the culture medium cannot result from cell lysis, because other intracellular enzymes and deoxyribonucleic acid are not released into the media. Hewlett et al. (14) described four distinct compartments with adenylate cyclase activity associated with B. pertussis. The majority of adenylate cyclase activity is associated with either the periplasmic space or the extracellular surface of the cytoplasmic membrane. A soluble fraction released into the culture medium comprises up to 20% of the total activity. Adenylate cyclase activities in these three compartments were sensitive to trypsin and accessible to exogenously added adenosine triphosphate (ATP), which is excluded from bacterial cells (27) . Approximately 7 to 9% of the total activity was associated with an intracellular pool of enzyme. The extracytoplasmic enzyme is heat labile; 90% of the activity is lost after heating at 57°C for 20 min. The activity of the enzyme is dependent on divalent metal cations, and maximal activity occurs in the presence of 5 to 10 mM MgCl2 (15) . The B. pertussis adenylate cyclase is not affected by a-keto acids, which have been reported to both stimulate and inhibit other bacterial adenylate cyclases (17, 19) . Various amphiphiles including phosphatidylcholine, phosphatidyl-ethanolamine, phosphatidylserine, and nonionic detergents of the Triton X series have a stimulatory effect on the Vmax of the enzyme with no effect on its Km for ATP (49 (16) first observed that the specific activity of the adenylate cyclase was much higher when the bacteria were grown on Bordet-Gengou blood agar rather than in Stainer-Scholte liquid synthetic media. Furthermore, they determined that the enzyme activity in the liquid media could be stimulated by the addition of either rabbit sera or an erythrocyte lysate. It was originally thought that hemoglobin activated the enzyme; however, when erythrocyte lysates were passed over a Sephadex G-100 column, the activator was separated from hemoglobin. It appeared that the activator was proteinaceous in nature, since it was sensitive to both trypsin and ox-chymotrypsin (12) . The activator of the enzyme was ultimately identified as calmodulin (50) . Calmodulin stimulation of the adenylate cyclase associated with whole bacterial cells is approximately 100-fold, while stimulation of the supernatant enzyme is generally less, 3-to 35- In contrast to the mammalian enzyme, the bacterial calmodulin-sensitive adenylate cyclase is insensitive to guanine nucleotides (15) . The two enzymes also differ in their Km for ATP; the brain enzyme has a Km of 0.03 mM (22) , whereas the bacterial adenylate cyclase has a Km of 0.4 to 1.0 mM (37).
PATHOGENICITY AND CELL INVASION Several lines of evidence suggest that B. pertussis adenylate cyclase is a toxin which contributes to the pathology of whooping cough. The enzyme is released extracellularly and is stimulated by a mammalian regulatory protein which is absent from bacteria. Hewelett et al. (13) determined that adenylate cyclase activity is greatly decreased in degraded strains of B. pertussis. This organism exists in at least four distinct serological phenotypes, designated as phases I, II, III, and IV. The variation from a fresh wild-type isolate (phase I) to a rough or degraded phenotype (phase IV) has been shown to represent a series of losses in antigenic and virulence-associated properties. Phase IV bacteria express significantly less adenylate cyclase activity than bacteria in phase I. When fresh clinical isolates are subjected to multiple passes, a loss of adenylate cyclase activity occurs. B. pertussis grown in synthetic media rich in MgSO4 undergoes a transformation to an avirulent phenotype having both decreased adenylate cyclase and IAP activity (1). Finally, Weiss and co-workers (48) (38) , human lymphocytes, S49 cyc-murine lymphoma cells, turkey erythrocytes, and rat oocytes (11) . Using crude urea extracts from intact bacteria, Confer and Eaton (4) and Hanski and Farfel (11) demonstrated an increase in intracellular cAMP that was apparently not due to endogenous adenylate cyclase activity. Shattuck Kessin and Franke (23) have reported 110-and 84-fold purification of high (700,000)-and low (50,000 to 65,000)-molecular-weight forms of the calmodulin-sensitive adenylate cyclase. They reported specific activities of 2.97 and 2.28 ,umol/min per mg for the large and small forms. These two forms were isolated from both culture media and urea extracts of intact bacteria. Their purification scheme includes hydrophobic and anion-exchange chromatography followed by gel filtration with an Ultrogel AcA 34 column. Calmodulin activation was 200-fold for the large form and 20-fold for the small form. Calmodulin-sensitive activity could be recovered from both sodium dodecyl sulfatepolyacrylamide and isoelectricfocusing gels. The 700,000 form of the enzyme migrated with two peaks of activity on an sodium dodecyl sulfate-polyacrylamide gel. The major peak of activity had a molecular weight of approximately 50,000, with a minor peak of activity observed at 65,000. The smaller form of the enzyme from gel filtration chromatography migrated as a single peak of activity with a molecular weight of approximately 50,000. There was not a Coomassie blue-stained protein band associated with adenylate cyclase activity. The data from this study suggest that the minimal molecular weight of the enzyme is 50,000 and that larger forms of the enzyme may be aggregates of the catalytic subunit with itself or another subunit.
Shattuck and co-workers (37) have obtained a significant purification of the soluble B. pertussis adenylate cyclase by using the purification protocol summarized in Table 2 . The first step in the purification is the removal of bacteria by centrifugation and application of the culture media to QAESephadex. Elution of the enzyme with a linear 0 to 1 M NaCl gradient results in the separation of two peaks of calmodulinsensitive adenylate cyclase activity, designated peaks I and II. Further purification of peak I adenylate cyclase activity is obtained by the addition of calmodulin to the pooled activity and reapplication to QAE-Sephadex. The addition of calmodulin to the adenylate cyclase activity significantly shifts the elution position of the enzyme on QAE-Sephadex and results in further purification of the enzyme. The specific activity of the calmodulin-shifted adenylate cyclase cannot be determined, however, due to contaminating levels of free calmodulin which elutes at the same position as the enzyme. preparation, the calmodulin-shifted peak I pool is applied to a fetuin-Sepharose column which absorbs IAP (36) but not adenylate cyclase. Adenylate cyclase preparations which had been passed over a fetuin-Sepharose column no longer contain any detectable IAP activity. Excess calmodulin is removed by gel filtration over an Ultrogel AcA 44 column. This purification protocol results in a 1,600-fold purification of the adenylate cyclase to a final specific activity of 608 ,umol of cAMP/min per mg, which is the highest specific activity reported for any adenylate cyclase. The molecular weight of the enzyme determined by sucrose density gradient centrifugation and gel filtration chromatography is 43,400 in the absence of calmodulin and 54,200 in the presence of calmodulin. Assuming a specific activity of 608 ,umol/min per mg, a molecular weight of 44,300, and one catalytic site per monomer, the minimum turnover number of the enzyme would be 27,000 per min.
The adenylate cyclase obtained by this purification protocol is an appropriate preparation to determine if the enzyme invades animal cells since the enzyme is extensively purified and contains no detectable IAP activity. Shattuck and Storm (38) have examined the effects of the purified adenylate cyclase on intracellular cAMP levels in erythrocytes. Erythrocytes are an excellent model system for examination of cell entry of the enzyme since they contain little or no endogenous adenylate cyclase activity and possess sufficient levels of ATP to be utilized as a substrate for the adenylate cyclase. Various adenylate cyclase preparations obtained during purification of the B. pertussis adenylate cyclase were incubated with human erythrocytes, and the cells were analyzed for the production of intracellular cAMP (Table 3) . Adenylate cyclase activity, which has been purified through the Ultrogel AcA 44 gel filtration column, does not increase intracellular cAMP levels in erythrocytes. Peak I adenylate cyclase activity, which is obtained from the first QAE- (38) .
b The enzyme was purified by the method described in Table 2 (37).
Sephadex column and subsequently applied to a fetuinSepharose column to remove IAP, does increase the intracellular cAMP levels in erythrocytes to a level of 325 pmol of cAMP per 109 cells.
There are two possible reasons why the highly purified adenylate cyclase from the Ultrogel AcA 44 column is unable to increase intracellular cAMP levels in erythrocytes. Since this preparation is more highly purified than peak I adenylate cyclase purified through fetuin-Sepharose and gel chromatography, it is possible that a component which facilitates cell entry of the adenylate cyclase is separated from catalytic activity. Alternatively, the more highly purified enzyme has calmodulin complexed to it, which may inhibit penetration of the enzyme into erythrocytes. Therefore, calmodulin was added to peak I adenylate cyclase which had been passed through fetuin-Sepharose and the calmodulin-enzyme complex was assayed for its effects on cAMP levels of erythrocytes (Table 3) . Addition of calmodulin to the enzyme completely inhibits the formation of intracellular cAMP catalyzed by the enzyme, indicating that the enzyme-calmodulin complex does not enter erythrocytes. This increase in cAMP in human erythrocytes contrasts with the results obtained by Hanski and Farfel (11) , who did not observe any increase in human erythrocytes with urea extracts obtained from whole bacteria.
The increase in cAMP in various eucaryotic cells with different preparations of bacterial adenylate cyclase is rapid. Using material purified as described above from culture supernatants, Shattuck et al. (37) 
